Dupilumab
R668-AD-1607
Phase 1 small_molecule completed
Quick answer
Dupilumab for Atopic Disorders is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Atopic Disorders
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed